NIAID/FAAN Clinical Criteria for Anaphylaxis Diagnosis

Diagnostic Criteria Overview

• The American Academy of Allergy, Asthma & Immunology, the American College of Allergy, Asthma & Immunology, and the World Allergy Organization endorse the NIAID/FAAN criteria, which define anaphylaxis when any one of three conditions is met: (1) acute skin/mucosal involvement plus respiratory compromise or hypotension; (2) sudden onset of ≥ 2 organ system symptoms after likely allergen exposure; or (3) isolated hypotension after exposure to a known allergen 1.

• Criterion 1 requires sudden onset (minutes‑to‑hours) of generalized hives, itching, flushing, or swollen lips/tongue/uvula plus either respiratory compromise (e.g., shortness of breath, wheeze, hypoxemia) or reduced blood pressure/end‑organ dysfunction 1.

• Criterion 2 is satisfied when, after a probable allergen exposure, at least two of the following appear abruptly: skin/mucosal symptoms, respiratory symptoms, hypotension/end‑organ dysfunction, or persistent gastrointestinal symptoms (e.g., crampy abdominal pain, vomiting) 1.

• Criterion 3 is met by isolated hypotension after exposure to a known allergen for that individual:

  • Adults – systolic BP < 90 mmHg or >30 % drop from baseline.
  • Infants (1 mo‑1 yr) – systolic BP < 70 mmHg.
  • Children (1‑10 yr) – systolic BP < 70 mmHg + (2 × age in years).
  • Children > 10 yr – systolic BP < 90 mmHg 1.

Blood Pressure Thresholds (Specific to Age Groups)

These thresholds are part of Criterion 3 for anaphylaxis diagnosis 1.

Clinical Pearls

• Skin findings are not required: 10‑20 % of anaphylaxis episodes present without any cutaneous signs, so clinicians must not await skin manifestations before diagnosing or treating 1.

• Epinephrine use is not limited to strict criteria: The guideline advises that epinephrine should be administered whenever anaphylaxis is suspected, even if the formal NIAID/FAAN criteria are not yet fully met (e.g., immediate urticaria after allergen immunotherapy) 1.

• Isolated hypotension or isolated respiratory symptoms can represent anaphylaxis without skin involvement, especially after insect stings or inhalant exposures 1.

Validation and Performance

• Prospective validation of the NIAID/FAAN criteria in emergency‑department populations demonstrated a positive likelihood ratio of 3.26 and a negative likelihood ratio of 0.07, supporting strong clinical utility for rapid diagnosis 1.

Timing of Symptom Onset

• Anaphylactic symptoms typically begin within minutes to several hours after allergen exposure; more rapid onset correlates with higher severity and a greater risk of life‑threatening outcomes 1.

Anaphylaxis Diagnostic Criteria

Introduction to Diagnostic Criteria

• The American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma, and Immunology, and the World Allergy Organization recognize the NIAID/FAAN diagnostic criteria as the widely endorsed and validated standard for diagnosing anaphylaxis in clinical practice as of 2020 2, 3, 4

Diagnostic Criteria

• The NIAID/FAAN criteria include three diagnostic criteria:

Validation and Clinical Performance

• The NIAID/FAAN criteria were prospectively validated in emergency department settings, demonstrating a positive likelihood ratio of 3.26 and negative likelihood ratio of 0.07, supporting their continued use in real-world clinical practice 4, 7

Clinical Application

• Epinephrine administration is not limited to patients meeting the formal diagnostic criteria, and clinical judgment should be used to determine the need for epinephrine 3, 7, 8
• Anaphylaxis can occur without skin involvement, and mild presentations or isolated symptoms can still meet diagnostic criteria 4, 7
• Isolated allergen-associated urticaria should be distinguished from anaphylaxis requiring prompt epinephrine, but impending anaphylaxis should not be delayed while waiting for additional criteria to develop 2, 7, 8

Diagnostic Criteria for Anaphylaxis

Overall Triggers for Immediate Diagnosis

• Anaphylaxis should be diagnosed immediately when any one of the following three clinical scenarios is present:

Detailed NIAID/FAAN Diagnostic Criteria

Criterion 1 – Skin/Mucosal Involvement + One Major System

• Acute onset (minutes‑to‑hours) of generalized hives, itching, flushing, or swelling of the lips/tongue/uvula plus at least one of the following major manifestations:

Criterion 2 – Two or More Organ Systems After Allergen Exposure

• Rapid onset after exposure to a likely allergen with any two of the following manifestations:

Criterion 3 – Isolated Hypotension After a Known Allergen

• Adults: systolic blood pressure < 90 mm Hg or a > 30 % drop from baseline. 11, 9, 10
• Infants (1 month–1 year): systolic blood pressure < 70 mm Hg. 9, 10
• Children (1–10 years): systolic blood pressure < 70 mm Hg + (2 × age in years). 9, 10
• Children > 10 years: systolic blood pressure < 90 mm Hg. 9, 10

Onset Timing of Anaphylactic Symptoms

• Clinical manifestations typically begin within minutes to several hours after allergen exposure. 9

Biphasic Reactions and Required Observation

These data are drawn from the same evidence base supporting the NIAID/FAAN criteria. 9, 10

Diagnosis When Symptoms Have Resolved

• Patients who present to the emergency department asymptomatic but whose history fulfills any NIAID/FAAN criterion should still be recorded as having anaphylaxis, even though immediate epinephrine administration is no longer indicated. 9, 10